SCHEMBL7925397

SCHEMBL7925397

N=C(N)NCCC[C@@H](NC(=O)c1ccccc1)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
C3AR1 Q16581 5/20 0.52
PADI1 Q9ULC6 5/20 0.51
PADI4 Q9UM07 5/20 0.51
PADI2 Q9Y2J8 4/20 0.51
PDE4A P27815 3/20 0.51
PADI3 Q9ULW8 3/20 0.51
PDE4B Q07343 2/20 0.51
PDE4C Q08493 2/20 0.51
PDE4D Q08499 2/20 0.51
PADI6 Q6TGC4 1/20 0.51
FOLH1 Q04609 2/20 0.47
CA2 P00918 4/20 0.47
GRIN1 Q05586 1/20 0.46
GRIN2A Q12879 1/20 0.46
ALB P02768 1/20 0.45
CA1 P00915 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL188590 1.00 C3AR1 (0.52) C3AR1PADI1PADI4PADI2PDE4A
SCHEMBL188589 1.00 C3AR1 (0.52) C3AR1PADI1PADI4PADI2PDE4A
Naphthalene SCHEMBL28216957 0.96 C3AR1 (0.49) C3AR1PADI1PADI4PADI2PDE4A
Alcohol SCHEMBL2258594 0.95 CA2 (0.49) C3AR1PADI1PADI4PADI2PDE4A
Alcohol SCHEMBL29029781 0.95 CA2 (0.49) C3AR1PADI1PADI4PADI2PDE4A
Propane SCHEMBL25417180 0.94 CA2 (0.48) C3AR1PADI1PADI4PADI2PDE4A
Butane SCHEMBL25420420 0.93 CA2 (0.50) C3AR1PADI1PADI4PADI2PDE4A
SCHEMBL10946109 0.92 PADI1 (0.60) C3AR1PADI1PADI4PADI2PDE4A
SCHEMBL158990 0.92 PADI1 (0.60) C3AR1PADI1PADI4PADI2PDE4A
Ether SCHEMBL9150674 0.92 C3AR1 (0.48) C3AR1PADI1PADI4PADI2PDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106163553-B Compositions of multimeric-multiepitope influenza polypeptides and production thereof 彼昂德瓦克斯医药有限公司 2021-07-23 CN disclosed
US-10426828-B2 Compositions of multimeric-multiepitope influenza polypeptides and their production BIONDVAX PHARMACEUTICALS LTD. (IL) 2019-10-01 US disclosed
US-20170173142-A1 COMPOSITIONS OF MULTIMERIC-MULTIEPITOPE INFLUENZA POLYPEPTIDES AND THEIR PRODUCTION BIONDVAX PHARMACEUTICALS LTD. (IL) 2017-06-22 US disclosed
EP-3125931-A1 COMPOSITIONS OF MULTIMERIC-MULTIEPITOPE INFLUENZA POLYPEPTIDES AND THEIR PRODUCTION Biondvax Pharmaceuticals Ltd. (IL) 2017-02-08 EP disclosed
WO-2015151103-A1 COMPOSITIONS OF MULTIMERIC-MULTIEPITOPE INFLUENZA POLYPEPTIDES AND THEIR PRODUCTION BIONDVAX PHARMACEUTICALS LTD. (IL) 2015-10-08 WO disclosed
EP-0821689-B1 TUMOR PROTEASE ACTIVATED PRODRUGS OF PHOSPHORAMIDE MUSTARD ANALOGS DRUG INNOVATION & DESIGN INC (US) 2001-07-04 EP disclosed
EP-0821689-A1 TUMOR PROTEASE ACTIVATED PRODRUGS OF PHOSPHORAMIDE MUSTARD ANALOGS Drug Innovation & Design, Inc. (US) 1998-02-04 EP disclosed
US-5659061-A Tumor protease activated prodrugs of phosphoramide mustard analogs with toxification and detoxification functionalities DRUG INNOVATION & DESIGN, INC. (US) 1997-08-19 US disclosed
WO-1996033198-A1 TUMOR PROTEASE ACTIVATED PRODRUGS OF PHOSPHORAMIDE MUSTARD ANALOGS DRUG INNOVATION & DESIGN, INC. (US) 1996-10-24 WO disclosed